Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200066225Phase 4Recruiting
Phase 4, randomised trial of ciprofol and dexmedetomidine in perioperative neurocognitive disorder and delirium (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: Incidence of delirium. Started Dec 2022; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200066225.